139 related articles for article (PubMed ID: 11240256)
21. Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat.
Grocott HP; Bart RD; Sheng H; Miura Y; Steffen R; Pearlstein RD; Warner DS
Stroke; 1998 Aug; 29(8):1650-5. PubMed ID: 9707208
[TBL] [Abstract][Full Text] [Related]
22. Increasing P(50) does not improve DO(2CRIT) or systemic VO(2) in severe anemia.
Eichelbrönner O; D'Almeida M; Sielenkämper A; Sibbald WJ; Chin-Yee IH
Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H92-101. PubMed ID: 12063279
[TBL] [Abstract][Full Text] [Related]
23. The effects of RSR13 on microvascular Po
Watanabe A; Poole DC; Kano Y
J Appl Physiol (1985); 2017 Oct; 123(4):764-772. PubMed ID: 28620055
[TBL] [Abstract][Full Text] [Related]
24. Effects of FI(O(2)) on hemodynamic responses and O(2) transport during RSR13-induced reduction in P(50).
Eichelbrönner O; Sielenkämper A; D'Almeida M; Ellis CG; Sibbald WJ; Chin-Yee IH
Am J Physiol; 1999 Jul; 277(1):H290-8. PubMed ID: 10409208
[TBL] [Abstract][Full Text] [Related]
25. Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
Najjar SS; Bottomley PA; Schulman SP; Waldron MM; Steffen RP; Gerstenblith G; Weiss RG
J Cardiovasc Magn Reson; 2005; 7(4):657-66. PubMed ID: 16136855
[TBL] [Abstract][Full Text] [Related]
26. Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
Fogh S; Machtay M; Werner-Wasik M; Curran WJ; Bonanni R; Axelrod R; Andrews D; Dicker AP
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1009-16. PubMed ID: 19879067
[TBL] [Abstract][Full Text] [Related]
27. Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model.
Burke TJ; Malhotra D; Shapiro JI
Kidney Int; 2001 Oct; 60(4):1407-14. PubMed ID: 11576354
[TBL] [Abstract][Full Text] [Related]
28. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
29. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation.
Khandelwal SR; Randad RS; Lin PS; Meng H; Pittman RN; Kontos HA; Choi SC; Abraham DJ; Schmidt-Ullrich R
Am J Physiol; 1993 Oct; 265(4 Pt 2):H1450-3. PubMed ID: 8238433
[TBL] [Abstract][Full Text] [Related]
30. Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy.
Nemoto K; Shibamoto Y; Ohmagari J; Baba Y; Ebe K; Ariga H; Takai Y; Ouchi A; Sasai K; Shinozaki M; Tsujitani M; Sakaguchi M; Yamada S; Sakamoto K
Anticancer Drugs; 2001 Jan; 12(1):1-6. PubMed ID: 11272282
[TBL] [Abstract][Full Text] [Related]
31. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
32. Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
Weiss RG; Mejia MA; Kass DA; DiPaula AF; Becker LC; Gerstenblith G; Chacko VP
J Clin Invest; 1999 Mar; 103(5):739-46. PubMed ID: 10074492
[TBL] [Abstract][Full Text] [Related]
33. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
Robertson JM; McGinn CJ; Walker S; Marx MV; Kessler ML; Ensminger WD; Lawrence TS
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1087-92. PubMed ID: 9392548
[TBL] [Abstract][Full Text] [Related]
34. RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry.
Breidbach A; Catlin DH
Rapid Commun Mass Spectrom; 2001; 15(24):2379-82. PubMed ID: 11746905
[TBL] [Abstract][Full Text] [Related]
35. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
Choy H; Yee L; Cole BF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
[TBL] [Abstract][Full Text] [Related]
36. Post-ischemic RSR13 amplifies the effect of dizocilpine on outcome from transient focal cerebral ischemia in the rat.
Mackensen GB; Nellgård B; Sarraf-Yazdi S; Dexter F; Steffen RP; Grocott HP; Warner DS
Brain Res; 2000 Jan; 853(1):15-21. PubMed ID: 10627303
[TBL] [Abstract][Full Text] [Related]
37. Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.
Kinsella T; Safran H; Wiersma S; DiPetrillo T; Schumacher A; Rosati K; Vatkevich J; Anderson LW; Hill KD; Kunos C; Collins JM
Clin Cancer Res; 2019 Oct; 25(20):6035-6043. PubMed ID: 31337643
[TBL] [Abstract][Full Text] [Related]
38. Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
Eisbruch A; Robertson JM; Johnston CM; Tworek J; Reynolds KR; Roberts JA; Lawrence TS
J Clin Oncol; 1999 Jan; 17(1):31-40. PubMed ID: 10458215
[TBL] [Abstract][Full Text] [Related]
39. Anemia, tumor hypoxemia, and the cancer patient.
Varlotto J; Stevenson MA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
[TBL] [Abstract][Full Text] [Related]
40. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
Schulz CA; Mehta MP; Badie B; McGinn CJ; Robins HI; Hayes L; Chappell R; Volkman J; Binger K; Arzoomanian R; Simon K; Alberti D; Feierabend C; Tutsch KD; Kunugi KA; Wilding G; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1107-15. PubMed ID: 15234045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
